In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic.
In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic, and a similar level of coordination is needed to ensure multichannel success.
Then, there’s the added challenge of managing interactions with today’s multifaceted customer, who could be a government agent; payer; physician (primary, specialist, or key opinion leader); nurse; hospital administrator; or Considering all the complexity in today’s life sciences industry, hitting the right note is much more difficult than just communicating through all channels. It requires a tremendous amount of coordination between sales, marketing and medical affairs.
In this article, Jan van den Burg looks at what companies need to do to execute a multichannel strategy that’s always in tune with the customer.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.